DXCM DEXCOM INC

Overview and Growth

In fiscal 2025, DEXCOM INC recorded $4.66B of revenue, net income of $836.30M, and an operating cash inflow of $1.44B. Revenue of $4.66B sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line expanded 15.6% from $4.03B in fiscal 2024, increasing the company’s operating scale. On a per-share basis, diluted EPS was $2.09, which connects the reported earnings outcome with the company’s diluted share count. The per-share result recorded a 47.2% increase from fiscal 2024 diluted EPS of $1.42. Revenue equaled 0.74x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

The first profit layer was $2.80B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 60.1% of revenue, showing how much of the top line remained after direct costs. Operations produced $911.80M of income after the reported operating expense base, before the remaining non-operating and tax effects. Relative to revenue, operating income represented 19.6%, showing how efficiently sales converted into operating profit. The bottom-line result was net income of $836.30M, after the operating, financing, tax, and other items recognized for the period. Measured against reported revenue, net income produced a 17.9% margin after operating costs and the remaining recognized items. Pretax income was $1.09B, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Pretax income represented 23.3% of revenue, placing earnings before tax in the context of the company’s operating scale. The reported income-tax provision was $252.10M, the amount recognized between pretax income and the final net-income result. The effective relationship between income tax and positive pretax income was 23.2%, without assuming a statutory-rate comparison. The relationship between net income and period-end equity was 30.5%, indicating the profitability achieved on book capital. Return on period-end assets was 13.2%, connecting net income with the company’s total asset base.

Liquidity and Capital Structure

At period end, the $6.34B asset base was financed through $3.59B of liabilities and $2.75B of equity. The near-term balance sheet paired $4.03B of current assets with $2.14B of current liabilities at the reporting date. The current ratio was 1.88x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $917.70M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 42.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The liabilities-to-assets relationship was 56.7%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 14.5% of total assets, showing the liquid cash component within the company’s broader resource base. Compared with $6.48B in fiscal 2024, the current asset base moved 2.2% and finished lower.

Cash Flow and Earnings Quality

The company reported $1.44B of operating cash flow, a cash inflow that shows the cash generated by operations. The operating-cash-flow-to-net-income relationship was 1.72x, comparing cash generated by operations with the bottom-line earnings result. Capital spending was $363.50M, absorbing part of the cash generated from operations before free cash flow. Capital spending absorbed 25.2% of operating cash flow, quantifying the share of cash from operations directed to investment. Free cash flow came to $1.08B, leaving a positive amount after capital expenditures. Relative to revenue, free cash flow equaled 23.1%, showing how much sales converted into cash after investment. Free cash flow equaled 17.0% of total assets, relating post-investment cash generation to the company’s resource base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.